SCHEMBL15380944

SCHEMBL15380944

CC12CCCC1C1CCC3=CC(=O)CC[C@]3(C)C1CC2

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 8/20 0.69
SHBG P04278 6/20 0.69
HSD17B10 Q99714 6/20 0.69
SMN1; SMN2 Q16637 6/20 0.69
LMNA P02545 5/20 0.69
ALDH1A1 P00352 5/20 0.69
SERPINA6 P08185 4/20 0.69
SNCA P37840 4/20 0.69
MAPK1 P28482 4/20 0.69
TSHR P16473 4/20 0.69
BLM P54132 3/20 0.69
PMP22 Q01453 3/20 0.69
NPSR1 Q6W5P4 3/20 0.69
HSD17B3 P37058 2/20 0.69
NR3C1 P04150 5/20 0.63
PGR P06401 5/20 0.63
ADRA1A P35348 1/20 0.63
HTR2B P41595 1/20 0.63
CYP3A4 P08684 4/20 0.62
AR P10275 4/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14532645 1.00 CYP19A1 (0.69) CYP19A1SHBGHSD17B10SMN1; SMN2LMNA
SCHEMBL18646434 1.00 CYP19A1 (0.69) CYP19A1SHBGHSD17B10SMN1; SMN2LMNA
SCHEMBL11860013 1.00 CYP19A1 (0.69) CYP19A1SHBGHSD17B10SMN1; SMN2LMNA
SCHEMBL950793 1.00 CYP19A1 (0.69) CYP19A1SHBGHSD17B10SMN1; SMN2LMNA
SCHEMBL13973080 1.00 CYP19A1 (0.69) CYP19A1SHBGHSD17B10SMN1; SMN2LMNA
SCHEMBL950792 1.00 CYP19A1 (0.69) CYP19A1SHBGHSD17B10SMN1; SMN2LMNA
SCHEMBL14455585 1.00 CYP19A1 (0.69) CYP19A1SHBGHSD17B10SMN1; SMN2LMNA
Androstenedione SCHEMBL21114424 0.87 CYP19A1 (0.71) CYP19A1SHBGHSD17B10SMN1; SMN2LMNA
SCHEMBL9157360 0.84 SHBG (0.66) CYP19A1SHBGHSD17B10SMN1; SMN2LMNA
SCHEMBL5925784 0.84 CYP19A1 (0.57) CYP19A1SHBGHSD17B10SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8580231-B2 Compositions and methods comprising magnetic resonance contrast agents NORTHWESTERN UNIVERSITY (US) 2013-11-12 US disclosed